HEMOGENYX PHARMACEUTICALS

Updated 9 days ago

Public Limited Company

Active - 08401609 (CH)
Age: 11 years
ID: 37300226/64

6th Floor, 60 Gracechurch Street, London, EC3V 0HR, United Kingdom

CLICK HERE TO SEE DETAILS OF COMPANY CHANGES

• 72110 - Research and experimental development on biotechnology

Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in New York City at its state-of-the-art research facility... The Company is a clinical-stage biopharmaceutical group developing new medicines and treatments for life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.

Also known as: Hemogenyx Pharmaceuticals LLC, HEMOGENYX PHARMACEUTICALS PLC

Previous names: SILVER FALCON PLC

Registration numbers: 08401609 (CH)

Primary location: London United Kingdom

SEARCH FOR SIMILAR COMPANIES

Interest Score

HIT Score

0.75

CEO

Dr Vladislav Sandler

Founder

Alexis M. Sandler, Dr Vladislav Sandler

UK Company Data

Company number 08401609	Account category GROUP	Account ref. day 31	Account ref. month 12
Accounts next due date 2024-06-30	Accounts last made up date 2022-12-31	Returns next due date 2017-03-13	Returns last made up date 2016-02-13
Num. mort. charges 0	Num. mort. outstanding 0	Num. mort. part. satisfied 0	Num. mort. satisfied 0
Num. gen. partners 0	Num. lim. partners 0

Domain

hemogenyx.com

Actual

hemogenyx.com

88.80.184.21

Status

Category

Company

HEMOGENYX PHARMACEUTICALS

UK Company Data

People Also Viewed